TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.740
+0.130 (8.07%)
At close: Dec 5, 2025, 4:00 PM EST
1.630
-0.110 (-6.32%)
After-hours: Dec 5, 2025, 5:42 PM EST
TherapeuticsMD Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 0.3 | -2.18 | -10.28 | 112 | -172.42 | -183.52 | |
| Depreciation & Amortization | 0.39 | 0.51 | 0.44 | 1.19 | 0.74 | 4.07 | |
| Other Amortization | - | - | - | - | - | 2.53 | |
| Asset Writedown & Restructuring Costs | 0.13 | 1.27 | 0.48 | - | - | 1.13 | |
| Stock-Based Compensation | 0.05 | 0.26 | 1.27 | 11.57 | 18.13 | 10.68 | |
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.24 | |
| Other Operating Activities | -0.43 | -0.35 | 2.45 | -111.32 | 93.83 | 8.75 | |
| Change in Accounts Receivable | - | - | - | - | - | -8.22 | |
| Change in Inventory | - | - | - | - | - | -3.34 | |
| Change in Accounts Payable | 0.03 | 0.23 | -2.14 | -1.21 | -1.06 | 1.89 | |
| Change in Other Net Operating Assets | 1.64 | 1.43 | -15.31 | -2.88 | 5.65 | 6.33 | |
| Operating Cash Flow | 2.07 | 0.73 | -48.14 | -4.08 | -142.69 | -159.47 | |
| Capital Expenditures | - | - | - | - | -0.03 | -0.21 | |
| Sale (Purchase) of Intangibles | - | - | - | -0.36 | -2.19 | -1.39 | |
| Other Investing Activities | - | - | - | 223.83 | - | - | |
| Investing Cash Flow | - | - | - | 223.48 | -2.22 | -1.6 | |
| Long-Term Debt Issued | - | - | - | - | - | 50 | |
| Long-Term Debt Repaid | - | - | - | -219.43 | -50 | - | |
| Net Debt Issued (Repaid) | - | - | - | -219.43 | -50 | 50 | |
| Issuance of Common Stock | - | - | 3.15 | 2.47 | 184.67 | 31.98 | |
| Other Financing Activities | - | - | - | -1.27 | -5.12 | -1.25 | |
| Financing Cash Flow | - | - | 3.15 | -235.21 | 129.55 | 80.73 | |
| Net Cash Flow | 2.07 | 0.73 | -44.99 | -15.81 | -15.36 | -80.34 | |
| Free Cash Flow | 2.07 | 0.73 | -48.14 | -4.08 | -142.73 | -159.68 | |
| Free Cash Flow Margin | 73.96% | 41.57% | -3697.46% | -5.83% | -5547.10% | -246.14% | |
| Free Cash Flow Per Share | 0.18 | 0.06 | -4.61 | -0.43 | -17.93 | -28.96 | |
| Cash Interest Paid | - | - | - | 13.55 | 25.07 | 25.85 | |
| Levered Free Cash Flow | -1.39 | -2.99 | -33.87 | 38.54 | -28.46 | -93.54 | |
| Unlevered Free Cash Flow | -1.39 | -2.99 | -33.87 | 38.54 | -28.46 | -78.21 | |
| Change in Working Capital | 1.67 | 1.66 | -17.45 | -4.09 | 4.59 | -3.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.